News

Biotech Chiefs Slam U.S. Report on Gene Patents

Anticipating a series of federal recommendations on gene patents coming out tomorrow, a former Senator and four executives at biotech companies and biotech trade groups criticized the Department of Health and Human Services (HHS) for taking, they said, a stand that would undermine the the technology transfer objectives of the Bayh-Dole Act and the biotech industry generally in the United States.

Based on draft proposals, HHS’s Secretary’s Advisory Committee on Genetics, Health and Society (SACGHS) is expected to issue six recommendations. The first is the most contentious, suggesting that Congress should enact laws to exempt gene patents from infringement liability—potentially allowing anyone to use any gene patent.

by Sam Kean

Full Story: http://blogs.sciencemag.org/scienceinsider/2010/02/biotech-execs-s.html

Posted in:

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.